A generic version of multiple sclerosis drug Copaxone was introduced in 2015, but it has done little to lower drug costs for MS patients, NPR reported. Yearly costs for MS drugs can run as high as $50 ...

Israel-based Teva Pharmaceutical is one of the largest global generic drug manufacturers, with a significant presence in the United States and in Western Europe. Generic drug manufacturers with large ...

The U.S. Food and Drug Administration's approval of Mylan N.V. MYL's generic version of Copaxone for the treatment of relapsing multiple sclerosis should be seen as a "clear negative" for Momenta ...

The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.

Sandoz, a global leader in generic pharmaceuticals and a subsidiary of Novartis, has received approval from the US Food and Drug Administration (FDA) for Glatopa, the first generic version of Teva's ...

WASHINGTON — Teva Pharmaceutical on Wednesday was denied in its suit to block approval of Mylan's and Sandoz' generic Copaxone, a multiple sclerosis drug, 10 days before the patent on the medication ...